Product NDC: | 49884-250 |
Proprietary Name: | Olanzapine and Fluoxetine |
Non Proprietary Name: | olanzapine and fuoxetine |
Active Ingredient(s): | 25; 6 mg/1; mg/1 & nbsp; olanzapine and fuoxetine |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49884-250 |
Labeler Name: | Par Pharmaceutical, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077742 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121128 |
Package NDC: | 49884-250-01 |
Package Description: | 100 CAPSULE in 1 BOTTLE, PLASTIC (49884-250-01) |
NDC Code | 49884-250-01 |
Proprietary Name | Olanzapine and Fluoxetine |
Package Description | 100 CAPSULE in 1 BOTTLE, PLASTIC (49884-250-01) |
Product NDC | 49884-250 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | olanzapine and fuoxetine |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20121128 |
Marketing Category Name | ANDA |
Labeler Name | Par Pharmaceutical, Inc |
Substance Name | FLUOXETINE HYDROCHLORIDE; OLANZAPINE |
Strength Number | 25; 6 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Atypical Antipsychotic [EPC],Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |